Mumbai - Glenmark Pharmaceuticals Ltd., an innovation-driven, global pharma company announced that it has been Great Place To Work Certified in India.

The company received this certification basis a detailed workplace culture assessment by the Great Place to Work based on their Trust Index and Culture Audit Frameworks. The Trust Index Framework captures the employee feedback around the five key dimensions of Trust, Respect, Fairness, Pride and Camaraderie, while the Culture Audit Framework captures design of people practices around Maximizing Human Potential, Values, Innovation for All, and Leadership Effectiveness. This certification is valid till February 2024.

On this recognition, Cheryl Pinto, Executive Director - Corporate Services, Glenmark Pharmaceuticals Ltd. said, 'We are truly honored and humbled to receive this recognition from Great Place to Work. It is a testament of our positive and inclusive workplace culture where the entire team feels valued, respected, and empowered to do their best at work. We will continue to strive for excellence in all that we do and to support our employees in achieving their full potential.'

The Institute's research shows that great workplaces are characterized by great leadership, consistent employee experience, and sustainable financial performance. These organizations can deliver a consistent experience to all their employees irrespective of their role, gender, tenure, or level. Their leaders believe in the vision of creating and sustaining a great place to work for all and role models being for all leaders.

About Great Place To Work

Great Place To Work is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. Their employee survey platform empowers leaders with the feedback, real-time reporting, and insights they need to make strategic people decisions. The Institute serves businesses, non-profits and government agencies in more than 60 countries and has conducted pioneering research on the characteristics of great workplaces for over three decades. In India, the institute partners with more than 1400 organizations annually across over 22 industries to help them build High-Trust, High-Performance Cultures designed to deliver sustained business results. Hundreds of CEOs and CXOs from India Inc. are part of the great place community that is committed to the vision of making India a great place to work for all.

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. (BSE: 532296 | NSE: GLENMARK) is an innovation-driven, global pharmaceutical company with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. In Vivo/Scrip 100 positions Glenmark amongst the Top 100 Companies Ranked by R&D and Pharmaceutical Sales, 2021; while Generics Bulletin/In Vivo places it in the Top 50 Generics and Biosimilars Companies Ranked by Sales, 2021. The company has been Great Place To Work Certified in India, in 2023. Glenmark has impacted over 2.6 million lives over the last decade through its CSR interventions.

Contact:

Udaykumar Murthy

Tel: +91 9960377617

Email: corpcomm@glenmarkpharma.com

(C) 2023 Electronic News Publishing, source ENP Newswire